EGFR FISH in colorectal cancer:: what is the current reality?

被引：33

作者：

Moroni, Mauro ^{[1
]}

Sartore-Bianchi, Andrea ^{[1
]}

Veronese, Silvio ^{[2
]}

Siena, Salvatore ^{[1
]}

机构：

[1] Niguarda Granda Hosp, Falck Div Med Oncol, I-20162 Milan, Italy

[2] Niguarda Granda Hosp, SC Div Pathol, I-20162 Milan, Italy

来源：

LANCET ONCOLOGY | 2008年 / 9卷 / 05期

关键词：

D O I：

10.1016/S1470-2045(08)70109-8

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：402 / 403

页数：2

共 10 条

[1] Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer [J].

Amado, Rafael G. ;

Wolf, Michael ;

Peeters, Marc ;

Van Cutsem, Eric ;

Siena, Salvatore ;

Freeman, Daniel J. ;

Juan, Todd ;

Sikorski, Robert ;

Suggs, Sid ;

Radinsky, Robert ;

Patterson, Scott D. ;

Chang, David D. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (10) :1626-1634

[2] Oncogenic activation of the RAS/RAF signaling pathway impairs the response of metastatic colorectal cancers to anti-epidermal growth factor receptor antibody therapies [J].

Benvenuti, Silvia ;

Sartore-Bianchi, Andrea ;

Di Nicolantonio, Federica ;

Zanon, Carlo ;

Moroni, Mauro ;

Veronese, Silvio ;

Siena, Salvatore ;

Bardelli, Alberto .

CANCER RESEARCH, 2007, 67 (06) :2643-2648

[3] EGFR FISH assay predicts for response to cetuximab in chemotherapy refractory colorectal cancer patients [J].

Cappuzzo, F. ;

Finocchiaro, G. ;

Rossi, E. ;

Jaenne, P. A. ;

Carnaghi, C. ;

Calandri, C. ;

Bencardino, K. ;

Ligorio, C. ;

Ciardiello, F. ;

Pressiani, T. ;

Destro, A. ;

Roncalli, M. ;

Crino, L. ;

Franklin, W. A. ;

Santoro, A. ;

Varella-Garcia, M. .

ANNALS OF ONCOLOGY, 2008, 19 (04) :717-723

[4] PTEN loss of expression predicts cetuximab efficacy in metastatic colorectal cancer patients [J].

Frattini, M. ;

Saletti, P. ;

Romagnani, E. ;

Martin, V. ;

Molinari, F. ;

Ghisletta, M. ;

Camponovo, A. ;

Etienne, L. L. ;

Cavalli, F. ;

Mazzucchelli, L. .

BRITISH JOURNAL OF CANCER, 2007, 97 (08) :1139-1145

[5] PIK3CA mutation/PTEN expression status predicts response of colon cancer cells to the epidermal growth factor receptor inhibitor cetuximab [J].

Jhawer, Minaxi ;

Goel, Sanjay ;

Wilson, Andrew J. ;

Montagna, Cristina ;

Ling, Yi-He ;

Byun, Do-Sun ;

Nasser, Shannon ;

Arango, Diego ;

Shin, Joongho ;

Klampfer, Lidija ;

Augenlicht, Leonard H. ;

Soler, Roman Perez ;

Mariadason, John M. .

CANCER RESEARCH, 2008, 68 (06) :1953-1961

[6] Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab [J].

Khambata-Ford, Shirin ;

Garrett, Christopher R. ;

Meropol, Neal J. ;

Basik, Mark ;

Harbison, Christopher T. ;

Wu, Shujian ;

Wong, Tai W. ;

Huang, Xin ;

Takimoto, Chris H. ;

Godwin, Andrew K. ;

Tan, Benjamin R. ;

Krishnamurthi, Smitha S. ;

Burris, Howard A., III ;

Poplin, Elizabeth A. ;

Hidalgo, Manuel ;

Baselga, Jose ;

Clark, Edwin A. ;

Mauro, David J. .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (22) :3230-3237

[7] Multicenter phase II and translational study of cetuximab in metastatic colorectal carcinoma refractory to irinotecan, oxaliplatin, and fluoropyrimidines [J].

Lenz, Heinz-Josef ;

Van Cutsem, Eric ;

Khambata-Ford, Shirin ;

Mayer, Robert J. ;

Gold, Philip ;

Stella, Philip ;

Mirtsching, Barry ;

Cohn, Allen L. ;

Pippas, Andrew W. ;

Azarnia, Nozar ;

Tsuchihashi, Zenta ;

Mauro, David J. ;

Rowinsky, Eric K. .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (30) :4914-4921

[8] KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab [J].

Lievre, Astrid ;

Bachet, Jean-Baptiste ;

Boige, Valerie ;

Cayre, Anne ;

Le Corre, Delphine ;

Buc, Emmanuel ;

Ychou, Marc ;

Bouche, Olivier ;

Landi, Bruno ;

Louvet, Christophe ;

Andre, Thierry ;

Bibeau, Frederic ;

Diebold, Marie-Daniele ;

Rougier, Philippe ;

Ducreux, Michel ;

Tomasic, Gorana ;

Emile, Jean-Francois ;

Penault-Llorca, Frederique ;

Laurent-Puig, Pierre .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (03) :374-379

[9] Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study [J].

Moroni, M ;

Veronese, S ;

Benvenuti, S ;

Marrapese, G ;

Sartore-Bianchi, A ;

Di Nicolantonio, F ;

Gambacorta, M ;

Siena, S ;

Bardelli, A .

LANCET ONCOLOGY, 2005, 6 (05) :279-286

[10] Epidermal growth factor receptor gene copy number and clinical outcome of metastatic colorectal cancer treated with panitumumab [J].

Sartore-Bianchi, Andrea ;

Moroni, Mauro ;

Veronese, Silvio ;

Carnaghi, Carlo ;

Bajetta, Emilio ;

Luppi, Gabriele ;

Sobrero, Alberto ;

Barone, Carlo ;

Cascinu, Stefano ;

Colucci, Giuseppe ;

Cortesi, Enrico ;

Nichelatti, Michele ;

Gambacorta, Marcello ;

Siena, Salvatore .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (22) :3238-3245

← 1 →